Red-Shifted Epac-Based FRET cAMP Sensors for All-Optical cAMP Control and Multiparameter Imaging
Cells · 06.07.2026 · 15 (13) · 1223
DOI: 10.3390/cells15131223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 06.07.2026. Verfasst von Tabea Kressmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Walther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University of Munich, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Fluorescence Resonance Energy Transfer, Cyclic AMP, Biosensing Techniques, Guanine Nucleotide Exchange Factors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation.
Abstract (Originalsprache)
Cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger downstream of G protein-coupled receptors (GPCRs) and a central regulator of cellular signaling. Genetically encoded exchange proteins directly activated by cAMP (Epac)-based Förster resonance energy transfer (FRET) biosensors enable real-time monitoring of cAMP dynamics in living cells, but commonly used cyan/yellow FRET pairs require short-wavelength excitation, limiting compatibility with multiplex imaging and blue-light optogenetic tools such as bacterial photoactivated adenylyl cyclases (bPACs). Here, we engineered and systematically characterized four red-shifted Epac-based single-chain FRET cAMP sensors combining yellow or orange FRET donors with red fluorescent FRET acceptors. Using ratiometric live-cell imaging, we quantified stimulus-evoked FRET responses and identified Epacred4 as the best-performing variant, showing an approximately 55% decrease in normalized FRET after forskolin stimulation. Epacred4 also reliably detected Gi/o-mediated decreases in cAMP following μ-opioid receptor activation. Brief 405 nm light pulses induced graded and reversible cAMP elevations using the low dark-activity variant bPAC-F198Y. Furthermore, Epacred4 enabled analysis of cAMP recovery kinetics during phosphodiesterase inhibition and multiplex imaging of cAMP and intracellular Ca2+ using Fura-2 with minimal spectral and pH-related interference under physiological imaging conditions. Together, Epacred4 represents a robust red-shifted cAMP sensor for optogenetic and multiplex signaling studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Walther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University of Munich, 80336 Munich, Germany.
- Institute of Pharmacy, Clinical Pharmacy, University of Regensburg, 93053 Regensburg, Germany.
- DZHK (German Centre for Cardiovascular Research), Munich Heart Alliance, 80336 Munich, Germany.
ORCID-Profile: Thomas Gudermann, Ursula Storch, Michael Mederos Y Schnitzler
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation
Zitieren
APA
Kressmann, T., Hermann, C., Treder, A., Gudermann, T., Storch, U., & Mederos Y Schnitzler, M. (2026). Red-Shifted Epac-Based FRET cAMP Sensors for All-Optical cAMP Control and Multiparameter Imaging. Cells, 15(13), 1223. https://doi.org/10.3390/cells15131223
Vancouver
Kressmann T, Hermann C, Treder A, Gudermann T, Storch U, Mederos Y Schnitzler M. Red-Shifted Epac-Based FRET cAMP Sensors for All-Optical cAMP Control and Multiparameter Imaging. Cells. 2026;15(13):1223. doi:10.3390/cells15131223
BibTeX
@article{Kressmann2026,
author = {Kressmann, Tabea and Hermann, Christian and Treder, Aaron and Gudermann, Thomas and Storch, Ursula and Mederos Y Schnitzler, Michael},
title = {Red-Shifted Epac-Based FRET cAMP Sensors for All-Optical cAMP Control and Multiparameter Imaging},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1223},
doi = {10.3390/cells15131223}
}
EUVIMED